In this study, we demonstrated the critical roles of KDM5B and its downstream target MALAT1 in triple negative breast cancer metastatic phenotype and clinical prognosis, based on the following observations: (i). The gene discussed is MALAT1; the disease is triple-negative breast carcinoma.